Deletion of the Vaccinia Virus B1 Kinase Reveals Essential Functions of This Enzyme Complemented Partly by the Homologous Cellular Kinase VRK2

Journal of Virology
Annabel T OlsonMatthew S Wiebe

Abstract

The vaccinia virus B1 kinase is highly conserved among poxviruses and is essential for the viral life cycle. B1 exhibits a remarkable degree of similarity to vaccinia virus-related kinases (VRKs), a family of cellular kinases, suggesting that the viral enzyme has evolved to mimic VRK activity. Indeed, B1 and VRKs have been demonstrated to target a shared substrate, the DNA binding protein BAF, elucidating a signaling pathway important for both mitosis and the antiviral response. In this study, we further characterize the role of B1 during vaccinia infection to gain novel insights into its regulation and integration with cellular signaling pathways. We begin by describing the construction and characterization of the first B1 deletion virus (vvΔB1) produced using a complementing cell line expressing the viral kinase. Examination of vvΔB1 revealed that B1 is critical for the production of infectious virions in various cell types and is sufficient for BAF phosphorylation. Interestingly, the severity of the defect in DNA replication following the loss of B1 varied between cell types, leading us to posit that cellular VRKs partly complement for the absence of B1 in some cell lines. Using cell lines devoid of either VRK1 or VRK2, we t...Continue Reading

References

May 9, 1998·Archives of Biochemistry and Biophysics·I ZelkoM Negishi
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·S McCraithS Fields
Jul 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·R ZhengR Craigie
Dec 3, 2003·The Journal of Biological Chemistry·R Jeremy Nichols, Paula Traktman
Dec 13, 2003·Journal of Virology·G DelhonD L Rock
Aug 22, 2007·Molecular and Cellular Biology·Sandra BlancoPedro A Lazo
Oct 17, 2007·Molecular and Cellular Biology·Tae-Hong KangKyong-Tai Kim
Nov 28, 2007·The Journal of Cell Biology·Oscar M LancasterHiroyuki Ohkura
Aug 21, 2008·Journal of Cell Science·Tae-Hong KangKyong-Tai Kim
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Dunja SkokoKiyoshi Mizuuchi
Nov 19, 2010·Journal of Virology·Thary JacobHerman W Favoreel
May 10, 2011·American Journal of Human Genetics·Xose S PuenteCarlos López-Otín
Jul 4, 2012·Cellular and Molecular Life Sciences : CMLS·Isabel F FernándezPedro A Lazo
Dec 27, 2012·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Kirsten A BratkeStefan Rothenburg
Feb 15, 2013·Journal of Virology·Wondimagegnehu M TeferiDavid H Evans
Jan 23, 2015·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Hadar Vinograd-BykEphrat Levy-Lahad
Apr 24, 2015·Journal of Virology·Zhilong YangBernard Moss

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Virology & CRISPR

This feed focuses on the virology of CRISPR and its use in developing CRISPR-Cas systems. Discover the latest research here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Advanced Imaging of Cellular Signaling

Cell signaling is a vital mechanism for communication within cells and outside with the environment. Several different signaling pathways have been found and advanced imaging techniques are being developed to visualize the molecules involved in these signaling pathways. Find the latest research in advanced imaging of cellular signaling here.